Page last updated: 2024-10-25

desipramine and Lung Diseases, Obstructive

desipramine has been researched along with Lung Diseases, Obstructive in 1 studies

Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.

Lung Diseases, Obstructive: Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gordon, GH1
Michiels, TM1
Mahutte, CK1
Light, RW1

Trials

1 trial available for desipramine and Lung Diseases, Obstructive

ArticleYear
Effect of desipramine on control of ventilation and depression scores in patients with severe chronic obstructive pulmonary disease.
    Psychiatry research, 1985, Volume: 15, Issue:1

    Topics: Aged; Carbon Dioxide; Clinical Trials as Topic; Depressive Disorder; Desipramine; Double-Blind Metho

1985